U.K. Migraine Treatment Market to 2032
Overview
The U.K. Migraine Treatment Market is expected to reach a 907.54 USD Billion by 2032 and is projected to grow at a CAGR of 24.20% from 2025 to 2032.
Revenue, 2024 (USD Billion)
324.47
Forecast, 2032 (USD Billion)
907.54
CAGR, 2024 - 2032
24.20%
Report Coverage
U.K.
U.K. Migraine Treatment Market 2018-2032 USD Billion
U.K. Migraine Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 324.47 USD Billion
- Projected Market Size (2032): 907.54 USD Billion
- CAGR (2025-2032): 24.20%
Key Findings of U.K. Migraine Treatment Market
- The U.K. Migraine Treatment Market was valued at 324.47 USD Billion in 2024.
- The U.K. Migraine Treatment Market is likely to grow at a CAGR of 24.20% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription in Product Type Segment accounted for the largest share of the market with a revenue of 267.11 USD Billion
- The fastest growing segment Preventive/ Prophylactic Treatment in Treatment Segment grew Fastest with a CAGR of 30.22% during the forecast period from 2024 to 2032.
U.K. Migraine Treatment Market Scope
U.K. Migraine Treatment Market Segmentation & Scope
Treatment
- Devices
- Non-Pharmacological Therapies
- Preventive/ Prophylactic Treatment
- Acute / Abortive Treatment
Types of Migraine
- Others
- Chronic
- Migraine with Aura
- Episodic
Distribution Channel
- Others
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
End User
- Others
- Homecare
- Clinics
- Hospitals
Type
- Branded
- Generic
Product Type
- Over The Counter
- Prescription
Route of Administration
- Others
- Nasal Sprays
- Parenteral
- Oral
U.K. Migraine Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2019 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 324.47 USD Billion |
| Market Value in 2032 | 907.54 USD Billion |
| CAGR (2025-2032) | 24.20% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Treatment,Types of Migraine,Distribution Channel,End User,Type,Product Type,Route of Administration |
Regional Insights:
-
Leading Market (2024-2032): U.K., leading in terms of revenue 324.47 USD Billion in 2024
- Key Country: U.K., leading in terms of revenue with value of 324.47 USD Billion in 2024.
Segments and Scope
-
U.K. Migraine Treatment Market to 2032, By Treatment
- Acute / Abortive Treatment is the largest segment in U.K. Migraine Treatment Market to 2032 with a revenue of 161.58 USD Billion in the year 2024.
- Preventive/ Prophylactic Treatment is the Fastest growing segment in U.K. Migraine Treatment Market to 2032 with a Growth rate of 19.45 % in forecast period 2025-2032.
-
U.K. Migraine Treatment Market to 2032, By Types of Migraine
- Episodic is the largest segment in U.K. Migraine Treatment Market to 2032 with a revenue of 177.53 USD Billion in the year 2024.
- Episodic is the Fastest growing segment in U.K. Migraine Treatment Market to 2032 with a Growth rate of 27.02 % in forecast period 2025-2032.
-
U.K. Migraine Treatment Market to 2032, By Distribution Channel
- Hospital Pharmacies is the largest segment in U.K. Migraine Treatment Market to 2032 with a revenue of 175.72 USD Billion in the year 2024.
- Online Pharmacies is the Fastest growing segment in U.K. Migraine Treatment Market to 2032 with a Growth rate of 24.42 % in forecast period 2025-2032.
-
U.K. Migraine Treatment Market to 2032, By End User
- Hospitals is the largest segment in U.K. Migraine Treatment Market to 2032 with a revenue of 166.07 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in U.K. Migraine Treatment Market to 2032 with a Growth rate of 26.19 % in forecast period 2025-2032.
-
U.K. Migraine Treatment Market to 2032, By Type
- Generic is the largest segment in U.K. Migraine Treatment Market to 2032 with a revenue of 247.05 USD Billion in the year 2024.
- Branded is the Fastest growing segment in U.K. Migraine Treatment Market to 2032 with a Growth rate of 22.73 % in forecast period 2025-2032.
-
U.K. Migraine Treatment Market to 2032, By Product Type
- Prescription is the largest segment in U.K. Migraine Treatment Market to 2032 with a revenue of 267.11 USD Billion in the year 2024.
- Prescription is the Fastest growing segment in U.K. Migraine Treatment Market to 2032 with a Growth rate of 25.03 % in forecast period 2025-2032.
-
U.K. Migraine Treatment Market to 2032, By Route of Administration
- Oral is the largest segment in U.K. Migraine Treatment Market to 2032 with a revenue of 254.23 USD Billion in the year 2024.
- Oral is the Fastest growing segment in U.K. Migraine Treatment Market to 2032 with a Growth rate of 24.64 % in forecast period 2025-2032.
U.K. Migraine Treatment Market Company Share Analysis
| Company Name |
|
||
| Novartis AG | |||
| Lilly | |||
| Teva Pharmaceuticals USA, Inc. | |||
| Bayer AG | |||
| Amgen Inc. | |||
U.K. Migraine Treatment Market Geographical Sales Distribution, 2018-2032 USD Billion
U.K. Migraine Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.K. Migraine Treatment Market is segmented based on Segmentation Treatment,Types of Migraine,Distribution Channel,End User,Type,Product Type,Route of Administration.
U.K. Migraine Treatment Market was valued at USD 324.47(Revenue in USD Billion) in 2019.
U.K. Migraine Treatment Market is projected to grow at a CAGR of 24.20% during the forecast period of 2024 to 2032.
The Prescription segment is expected to dominate the U.K. Migraine Treatment Market, holding a largest market share of 267.11 USD Billion in 2024
U.K. Migraine Treatment Market Scope
U.K. Migraine Treatment Market Segmentation & Scope
Treatment
- Devices
- Non-Pharmacological Therapies
- Preventive/ Prophylactic Treatment
- Acute / Abortive Treatment
Types of Migraine
- Others
- Chronic
- Migraine with Aura
- Episodic
Distribution Channel
- Others
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
End User
- Others
- Homecare
- Clinics
- Hospitals
Type
- Branded
- Generic
Product Type
- Over The Counter
- Prescription
Route of Administration
- Others
- Nasal Sprays
- Parenteral
- Oral
Frequently Asked Questions
The U.K. Migraine Treatment Market is segmented based on Segmentation Treatment,Types of Migraine,Distribution Channel,End User,Type,Product Type,Route of Administration.
U.K. Migraine Treatment Market was valued at USD 324.47(Revenue in USD Billion) in 2019.
U.K. Migraine Treatment Market is projected to grow at a CAGR of 24.20% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Migraine Treatment Market for final year is USD 907.54 (USD Billion).
U.K. Migraine Treatment Market Company Profiling
Frequently Asked Questions
The U.K. Migraine Treatment Market is segmented based on Segmentation Treatment,Types of Migraine,Distribution Channel,End User,Type,Product Type,Route of Administration.
U.K. Migraine Treatment Market was valued at USD 324.47(Revenue in USD Billion) in 2019.
U.K. Migraine Treatment Market is projected to grow at a CAGR of 24.20% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Migraine Treatment Market for final year is USD 907.54 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.